Next Article in Journal
Viruses and Cajal Bodies: A Critical Cellular Target in Virus Infection?
Next Article in Special Issue
The Novel Porcine Parvoviruses: Current State of Knowledge and Their Possible Implications in Clinical Syndromes in Pigs
Previous Article in Journal
COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome
Previous Article in Special Issue
Pathogenicity Studies of NADC34-like Porcine Reproductive and Respiratory Syndrome Virus LNSY-GY and NADC30-like Porcine Reproductive and Respiratory Syndrome Virus GXGG-8011 in Piglets
 
 
Review
Peer-Review Record

Research Progress of Porcine Reproductive and Respiratory Syndrome Virus NSP2 Protein

Viruses 2023, 15(12), 2310; https://doi.org/10.3390/v15122310
by Benjin Liu 1,†, Lingzhi Luo 1,†, Ziqi Shi 1, Houbin Ju 2, Lingxue Yu 3,*, Guoxin Li 3 and Jin Cui 1,*
Reviewer 1: Anonymous
Viruses 2023, 15(12), 2310; https://doi.org/10.3390/v15122310
Submission received: 30 October 2023 / Revised: 21 November 2023 / Accepted: 22 November 2023 / Published: 24 November 2023
(This article belongs to the Special Issue Porcine Viruses 2023)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

I noticed that in some parts of the test there are too many spaces and in others there are none:

Abstract fisrt line after prevalent;

Introduction ( Table 1)

Paragraph 2.2.  twelfth line pseudoknot) ,

                        lethal(75,81). tradionally  

Paragraph 3.1. (83, 84).PRRSV

                        ( NSP2a

                        (83) .

Paragraph 3.2.1.  (88).PRRSV

                             TBK1.Phosphorylated

                               proteins.The

                            ISG.ISG15

                             (90).NSP2

Figure 2 IKB  or

Paragraph 3.3. [10].Ca2+

                        autophagy .PRRSV

                       demonstrated. , Meanwhile

                       4h.

Conclusions              cycle.  In addition

 

Some word in italic form: in vitro or in vivo (Table 2 and Paragraph 2.1.)

In paragraph 3.3. Ca2+ must be replaced with Ca2+

For the bibliography in the test i suggest to insert more references in the paragraphs 3.3. and 3.4.

In the paragraph 3.1. the name  of autohr must be replaced with number of reference (Nan H, 2018)

In the figure 3 caption STIMI is must be replaced with STIM1 and in the figure 4 AIFI is must be replaced with AIF1, as in the text of paragraph 3.4.

Moreover, I'm not sure if the order of references is correct, please check the authors instructions.

 

Author Response

Dear editor and reviewers,

Thank you very much for the reviewing process of our manuscript entitled “Research Progress of Porcine Reproductive and Respiratory Syndrome Virus NSP2 Protein” (ID: viruses-2718368).  We also highly appreciate the reviewer’s carefulness, conscientiousness, and beneficial suggestions. Those comments are all valuable and very helpful for revising and improving our paper, as well as guiding to our research. We have gone through the manuscript very carefully, and made some improvements as suggested in the revised manuscript. These changes will not influence the overall content and framework of the paper. We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments. If we still have problems or faults, please tell us, we will try our best to revise. We appreciate for Editors/Reviewers’ warm work earnestly, and hope that the correction will meet with approval.

Specifically, We carefully corrected some white space, superscript, italics, and protein name writing problems, and re-screened and corrected the whole article.   In addition, we inserted more references in paragraphs 3.3 and 3.4 to make our statements more evidence-based. Next, the name of the author of "(Nan H, 2018)" in paragraph 3.1 has been replaced with a reference number. Finally, we have checked the authors instructions, and there was also some adjustment in the order of the references due to the citation of the new references. The revised version includes newly introduced discussions and references, presented in the Word version of the manuscript in modified mode or marked in red. Please see the attachment.

Once again, thank you very much for your comments and suggestions.

Yours sincerely

Jin Cui

E-mail: jincui@neau.edu.cn

 

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Comments for the authors

Major comments

A.     You should discuss the recent reports of a PRRSV strain of enhanced virulence in Europe (PRRSV L1C 1-2-4, Rosalia  / Italy and Spain). Please send for example the following references 

Martín-Valls, G.E., Cortey, M., Allepuz, A. et al. Introduction of a PRRSV-1 strain of increased virulence in a pig production structure in Spain: virus evolution and impact on production. Porc Health Manag 9, 1 (2023). https://doi.org/10.1186/s40813-022-00298-3

Claudia Romeo, Giovanni Parisio, Federico Scali, Matteo Tonni, Giovanni Santucci, Antonio M. Maisano, Ilaria Barbieri, M. Beatrice Boniotti, Tomasz Stadejek, G. Loris Alborali. Complex interplay between PRRSV-1 genetic diversity, coinfections and antimicrobial use influences performance parameters in post-weaning pigs. Veterinary Microbiology, Volume 284, 2023, 109830,

B.     You should discuss the recent research on PRRSV vaccinology in relation to Nsp2 protein 

Author Response

Dear editor and reviewers,

Thank you very much for the reviewing process of our manuscript entitled “Research Progress of Porcine Reproductive and Respiratory Syndrome Virus NSP2 Protein” (ID: viruses-2718368).  We also highly appreciate the reviewer’s carefulness, conscientiousness, and beneficial suggestions. Those comments are all valuable and very helpful for revising and improving our paper, as well as guiding to our research. We have gone through the manuscript very carefully, and made some improvements as suggested in the revised manuscript. These changes will not influence the overall content and framework of the paper. We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments. If we still have problems or faults, please tell us, we will try our best to revise. We appreciate for Editors/Reviewers’ warm work earnestly, and hope that the correction will meet with approval.

Responses to A:

Thank you very much for your comments. We have discussed the strain and cited the corresponding references in paragraph 1.1.                                              Please see Line-13 of the paragraph 1.1 of manuscript.

Responses to B:

Thank you very much for raising an important knowledge point about nsp2, but we just missed it.  In Section 3.2.2, we discuss the relationship between nsp2 and vaccines, and the corresponding references are attached, which enriches the content of our article.  Thank you again for your valuable comments            Please see the third paragraph of Section 3.2.2 of manuscript.

Once again, thank you very much for your comments and suggestions.

Yours sincerely                                                                                                        Jin Cui                                                                                                                      E-mail: jincui@neau.edu.cn

 

Author Response File: Author Response.pdf

Back to TopTop